Tokyo, Japan

Shigeto Fukushima

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 7.1

ph-index = 5

Forward Citations = 48(Granted Patents)


Location History:

  • Narashino, JP (2000 - 2012)
  • Tokyo, JP (2016 - 2021)
  • Kawasaki, JP (2022)

Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Shigeto Fukushima: Innovator in Nucleic Acid Delivery Systems

Introduction

Shigeto Fukushima is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of nucleic acid delivery systems, holding a total of 10 patents. His innovative work focuses on improving the efficiency and effectiveness of delivering nucleic acids to target sites in patients.

Latest Patents

Fukushima's latest patents include a "Nucleic acid-loaded unit polyion complex." This invention describes a unit-type polyion complex designed for delivering nucleic acid to a target site in a patient. It comprises one or more molecules of a block copolymer featuring a poly(ethylene glycol) segment and a cationic poly(amino acid) segment. The total quantity of positive charges from the cationic poly(amino acid) segment is not offset by the negative charges from the nucleic acid. Additionally, the nucleic acid has a strand length of 10-50 bases, and the block copolymer has a binding constant (Ka) for the nucleic acid of 3.0 or more.

Another notable patent is the "Unit structure-type pharmaceutical composition for nucleic acid delivery." This composition includes a single nucleic acid, such as an antisense nucleic acid, electrostatically bound to a block copolymer with a cationic polyamino acid segment and a hydrophilic polymer chain segment. The negative charges of the nucleic acid are counterbalanced by the positive charges of the cationic polyamino acid segment, resulting in an electrically neutral or nearly electrically neutral pharmaceutical composition. The hydrophilic polymer chain segment enhances the blood retention capability of the nucleic acids.

Career Highlights

Fukushima has worked with esteemed institutions, including The University of Tokyo and Nanocarrier Co., Ltd. His research and innovations have significantly advanced the field of drug delivery systems, particularly in the area of nucleic acids.

Collaborations

He has collaborated with notable colleagues such as Kazunori Kataoka and Nobuhiro Nishiyama, contributing to the development of groundbreaking technologies in the pharmaceutical industry.

Conclusion

Shigeto Fukushima's work in nucleic acid delivery systems exemplifies the impact of innovative thinking in medicine. His patents and collaborations continue to influence the field, paving the way for future advancements in drug delivery

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…